124 related articles for article (PubMed ID: 26035348)
1. Cyclopropyl-methoxycarbonyl Metomidate: Studies in a Lipopolysaccharide Inflammatory Model of Sepsis.
Santer P; Pejo E; Feng Y; Chao W; Raines DE
Anesthesiology; 2015 Aug; 123(2):368-76. PubMed ID: 26035348
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.
Ge R; Pejo E; Cotten JF; Raines DE
Crit Care; 2013 Jan; 17(1):R20. PubMed ID: 23363638
[TBL] [Abstract][Full Text] [Related]
3. Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metabolite.
Pejo E; Liu J; Lin X; Raines DE
Anesth Analg; 2016 Apr; 122(4):1008-14. PubMed ID: 26991617
[TBL] [Abstract][Full Text] [Related]
4. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs.
Ge R; Pejo E; Husain SS; Cotten JF; Raines DE
Anesthesiology; 2012 Nov; 117(5):1037-43. PubMed ID: 22929726
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.
Pejo E; Feng Y; Chao W; Cotten JF; Le Ge R; Raines DE
Crit Care Med; 2012 Jan; 40(1):187-92. PubMed ID: 21926608
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis.
Wang B; Jiang J; Yang J; Chen J; Zhu Z; Liu J; Zhang W
Eur J Pharm Sci; 2017 Nov; 109():441-445. PubMed ID: 28882766
[TBL] [Abstract][Full Text] [Related]
8. Etomidate derivatives: Novel pharmaceutical agents in anesthesia.
Malapero RJ; Zaccagnino MP; Brovman EY; Kaye AD; Urman RD
J Anaesthesiol Clin Pharmacol; 2017; 33(4):429-431. PubMed ID: 29416230
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of cyclopropyl-methoxycarbonyl metomidate: a comparison with propofol.
Ge R; Pejo E; Gallin H; Jeffrey S; Cotten JF; Raines DE
Anesth Analg; 2014 Mar; 118(3):563-7. PubMed ID: 24557104
[TBL] [Abstract][Full Text] [Related]
10. Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats.
Jiang J; Wang B; Zhu Z; Yang J; Liu J; Zhang W
PeerJ; 2017; 5():e3693. PubMed ID: 28890850
[TBL] [Abstract][Full Text] [Related]
11. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.
Cotten JF; Le Ge R; Banacos N; Pejo E; Husain SS; Williams JH; Raines DE
Anesthesiology; 2011 Oct; 115(4):764-73. PubMed ID: 21572317
[TBL] [Abstract][Full Text] [Related]
12. Sedative-hypnotic Binding to 11β-hydroxylase.
Pejo E; Zhou X; Husain SS; Raines DE
Anesthesiology; 2016 Nov; 125(5):943-951. PubMed ID: 27541316
[TBL] [Abstract][Full Text] [Related]
13. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
[TBL] [Abstract][Full Text] [Related]
14. Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects.
Valk BI; Absalom AR; Meyer P; Meier S; den Daas I; van Amsterdam K; Campagna JA; Sweeney SP; Struys MMRF
Br J Anaesth; 2018 Jun; 120(6):1401-1411. PubMed ID: 29793605
[TBL] [Abstract][Full Text] [Related]
15. An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
Wang B; Yang J; Chen J; Kang Y; Yang LH; Liu J; Zhang WS
Anesth Analg; 2017 Aug; 125(2):442-450. PubMed ID: 28514325
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats.
McGrath M; Hofmann A; Raines DE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):48. PubMed ID: 31383012
[TBL] [Abstract][Full Text] [Related]
17. Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs.
Yang J; Kang Y; Wang B; Yang L; Liu J; Zhang W
Eur J Pharm Sci; 2017 Mar; 99():343-349. PubMed ID: 28057551
[TBL] [Abstract][Full Text] [Related]
18. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
Husain SS; Pejo E; Ge R; Raines DE
Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
[TBL] [Abstract][Full Text] [Related]
19. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
[TBL] [Abstract][Full Text] [Related]
20. The pituitary adenylate cyclase-activating polypeptide (PACAP) protects adrenal function in septic rats administered etomidate.
Liu N; Zhang Y; Xiong JY; Liu S; Zhu J; Lv S
Neuropeptides; 2016 Aug; 58():53-9. PubMed ID: 27103538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
